Skip to search formSkip to main contentSkip to account menu

G(M2) Ganglioside

Known as: G(M2) Ganglioside [Chemical/Ingredient], Ganglioside, Tay-Sachs Disease, GM2, Ganglioside 
A glycosphingolipid antigen expressed by a variety of human cancer cells. GM2 containing vaccines have been shown to elicit antibodies production in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Purpose: The paper analyses the influence of plastic deformation in cold working process on the texture and structure of X5CrNi18… 
Highly Cited
2000
Highly Cited
2000
GM2 ganglioside is a potential peripheral nerve antigen for neuropathy-associated autoantibodies. However little data are… 
1999
1999
HIV-infected cells aberrantly express a high level of antigenic glycosidic structures such as GM2 and Gg4. Some normal sera… 
1999
1999
ABSTRACT The hemagglutinin, esterase, and fusion (HEF) glycoprotein of influenza C virus possesses receptor binding, receptor… 
Highly Cited
1997
Highly Cited
1997
Abstract Natural IgM antibodies against the melanoma cell-surface ganglioside GM2, and IgM antibodies induced by vaccination with… 
1996
1996
Ganglioside GM2, expressed on the surface of some human cancers, is a promising target for immune therapy, since GM2 antibodies… 
1995
1995
Gangliosides expressed in malignant melanoma are potential targets for immunotherapy. Immunization of melanoma patients with… 
Highly Cited
1988
Highly Cited
1988
Since the preliminary analyses of the glycolipids of small cell carcinomas of the lung showed an increase of GM2 ganglioside, we… 
1969
1969
Abstract— Gangliosides G1 to G5 were isolated from human brain by means of TLC and tested with respect to their specificity to…